过去一年中添加的文章,按日期排序

[HTML][HTML] A review of current mRNA-based cancer vaccinations with special consideration for future breast cancer prevention strategies

A She, A Cornwell, F Jenney - 2024 - digitalcommons.pcom.edu
2 天前 - … current clinical trials with mRNA-based vaccines. … trial phases. mRNA has been
used successfully to mitigate infectious disease - a prime example being the COVID-19 vaccine. …

… , and immunogenicity of Ad26. COV2. S as homologous or heterologous COVID-19 booster vaccination: Results of a randomized, double-blind, phase 2 trial

M Le Gars, J Sadoff, V Cárdenas, D Heerwegh… - Vaccine, 2024 - Elsevier
2 天前 - COVID-19 vaccine boosters may optimize durability of protection against variants
of concern (VOCs). In this randomized, double-blind, phase 2 trial, … of COVID-19 vaccine

[PDF][PDF] See a need, fill a need: Altruism characterizes menstruation research participation among marginalized groups during the COVID-19 pandemic

EJ Junkins, S Chehab, KMN Lee, KBH Clancy - osf.io
2 天前 - … Despite the success of the COVID-19 vaccine rollout, trust … side effects after
COVID-19 vaccination. We investigated … The COVID-19 vaccine trials by Pfizer and Moderna, the …

A Theory and Evidence-Based Artificial Intelligence-Driven Motivational Digital Assistant to Decrease Vaccine Hesitancy: Intervention Development and Validation

Y Li, KC Lee, D Bressington, Q Liao, M He, KK Law… - Vaccines, 2024 - mdpi.com
3 天前 - COVID-19 vaccines (ie, not taking COVID-19 vaccines or receiving involuntary
COVID-19 vaccines) … This study lays a foundation for conducting a randomized controlled trial to …

[HTML][HTML] … versus homologous COVID-19 booster vaccinations for adults: systematic review with meta-analysis and trial sequential analysis of randomised clinical trials

MA Asante, ME Michelsen… - BMC …, 2024 - bmcmedicine.biomedcentral.com
4 天前 - … After identifying eligible randomised clinical trials for our original research on the
efficacy of all COVID-19 vaccines in relation to all-cause mortality, safety, and vaccine efficacy, …

[HTML][HTML] Efficacy and Safety of Remdesivir in People With Impaired Kidney Function Hospitalized for COVID-19 Pneumonia: A Randomized Clinical Trial

ME Sise, JR Santos, JD Goldman… - Clinical Infectious …, 2024 - academic.oup.com
4 天前 - … Key Points Remdesivir was safe in this randomized Phase 3 trial in hospitalized
participants with COVID-19 and severe kidney impairment. No significant difference was found …

[HTML][HTML] Factors associated with acceleration of clinical development for infectious diseases: a cross-sectional analysis of 10-year EMA registration data

HK de Jong, SM Hermans, SM Schuitenmaker… - The Lancet Regional …, 2024 - Elsevier
4 天前 - … Among the 81 clinical trial trajectories included, the shortest development times
were recorded for registered COVID-19 vaccine and drug clinical trial trajectories. The second-…

Using simulation modeling to inform intervention and implementation selection in a rapid stakeholder-engaged hybrid effectiveness-implementation randomized trial

JE Becker, FM Shebl, E Losina… - Implementation …, 2024 - pubmed.ncbi.nlm.nih.gov
4 天前 - … We describe the use of a simulation model of the effectiveness of COVID-19
mitigation strategies to inform a stakeholder-engaged process of rapidly designing a tailored …

Pitfalls in the detection of anti-Nucleolar Organizer Region 90 (NOR90) antibodies

S Kamiya, Y Muro, Y Yamashita… - European Journal of …, 2024 - ejinme.com
6 天前 - coronavirus disease 2019 (Covid-19) vaccine. She was referred to our hospital for
a thorough examination because her previous physician had found anti-nuclear antibodies. …

Factors, motivations and barriers associated with eagerness to volunteer in COVID-19 vaccine clinical trials in France: A mixed-method study

A Helary, E Botelho-Nevers, M Bonneton, L Khennouf… - Vaccine, 2024 - Elsevier
6 天前 - … to COVID-19 VCTs. … COVID-19 vaccination campaign, middle volunteers (MV)
registered between the first of January 2021 and the generalization of the COVID-19 vaccination